|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| A61K 31/497 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| C07D 403/12 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 31/00 | (2006.01) |
| (11) | Patento numeris | 3180331 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15754099.8 |
| Europos patento paraiškos padavimo data | 2015-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/045395 |
| Data | 2015-08-14 |
| (87) | Numeris | WO 2016/025904 |
| Data | 2016-02-18 |
| (30) | Numeris | Data | Šalis |
| 201462038069 P | 2014-08-15 | US |
| (72) |
AUSTAD, Brian Clinton , US
ROE, David G. , CA
|
| (73) |
Karyopharm Therapeutics Inc. ,
85 Wells Avenue, Newton, MA 02459,
US
|
| (54) | POLYMORPHS OF SELINEXOR |
| POLYMORPHS OF SELINEXOR |